Increased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis. [electronic resource]
Producer: 19930525Description: 121-4 p. digitalISSN:- 1042-8194
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- cerebrospinal fluid
- Child
- Child, Preschool
- Combined Modality Therapy
- Cranial Irradiation
- Female
- Humans
- Injections, Spinal
- Leukemic Infiltration -- drug therapy
- Leukocyte Count
- Male
- Meninges -- pathology
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Proteins -- cerebrospinal fluid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Predictive Value of Tests
- Prognosis
- Remission Induction
- Risk Factors
- Thymidine Kinase -- cerebrospinal fluid
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.